---
$id: https://graph.org.ai/products/commodity/51162705
$type: Product
source: UNSPSC
code: "51162705"
title: "Brovanexine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brovanexine

**UNSPSC Code**: 51162705
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent with the molecular formula C24H28Br2N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Y00SD533IW, chemically known as 4-acetoxy-2,4-dibrom-6-((n-cyclohexylmethylamino)methyl)-3-methoxybenzanilid but more generally known as brovanexine, which bears US NIH Compound Identifier 162137. Brovanexine most often comes in base and hydrochloride forms. European Medicines Agency schedules Brovanexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05934MIG. The term BROVANEXINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). BROVANEXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule brovanexine under HS 29242995 and SITC 51479. As of Q4 2014, BROVANEXINE remains US FDA's Preferred Term for this commodity. Brovanexine bears US NLM identifiers UMLS ID C0054152 and NCI Concept Code C74261. SMILES: BRC1C(NC(=O)C2CC(OC)C(OC(=O)C)CC2)C(CN(C2CCCCC2)C)CC(BR)C1.

